Literature DB >> 7828625

Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexes.

R D Abeysinghe1, B L Ellis, J B Porter.   

Abstract

In order to identify new compounds which label platelets without affecting their function, three classes of metal chelating agents have been compared with oxine for their efficiency of indium-113m platelet labelling and for their short- and long-term effects on platelet function. The 3-hydroxypyridinones (both 2-ones and 4-ones) and 3-hydroxypyranones are bidentate chelators of trivalent metal ions that are neutrally charged in the metal-complexed form and hence gain access to cells readily. The hydroxypyranone ethylmaltol has been compared with the 3-hydroxypyridin-4-one CP94 and to its structurally related lipophilic analogue CP25 as well as with the 3-hydroxypyridin-2-one, CP02. The platelet labelling efficiencies with these ligands were between 75% and 95% of that obtained with oxine, following a 12-min incubation in saline. The optimal concentration for the hydroxypyridin-2-ones and hydroxypyridin-4-ones was approximately 10 microM compared with 100 microM for the hydroxypyranone ethylmaltol and 60 microM for oxine. Oxine and tropolone were found to produce significant inhibition of platelet aggregation to collagen in short-term experiments (10 min) or in longer term (18 and 42 h) ex vivo platelet cultures respectively. By contrast, ethylmaltol had no such inhibitory effects at either time interval. The relatively hydrophilic hydroxypyridin-4-one CP94 showed no inhibitory effects on collagen-induced aggregation in short-term studies, unlike the more lipid-soluble derivative CP25. These results suggest that ethylmaltol and related pyranones may have advantages over oxine and tropolone as indium platelet labelling agents where it is important not to damage platelets by the labelling process itself.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7828625     DOI: 10.1007/bf00181071

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  31 in total

Review 1.  Clinically useful chelators of tripositive elements.

Authors:  R C Hider; A D Hall
Journal:  Prog Med Chem       Date:  1991

2.  Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.

Authors:  S Vallabhajosula; J Machac; S J Goldsmith; H Lipszyc; L Badimon; J Rand; V Fuster
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

3.  Indium (111In)-labelled human platelets: optimal method.

Authors:  R J Hawker; L M Hawker; A R Wilkinson
Journal:  Clin Sci (Lond)       Date:  1980-03       Impact factor: 6.124

4.  Neutrophil labeling with indium-111: tropolone vs. oxine.

Authors:  K P Gunter; J N Lukens; J A Clanton; P J Morris; R L Janco; D English
Journal:  Radiology       Date:  1983-11       Impact factor: 11.105

5.  Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters.

Authors:  M K Dewanjee; S A Rao; P Didisheim
Journal:  J Nucl Med       Date:  1981-11       Impact factor: 10.057

6.  Indium-111 tropolone, a new tracer for platelet labeling.

Authors:  M K Dewanjee; S A Rao; J A Rosemark; S Chowdhury; P Didisheim
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

7.  Simplified and efficient labeling of human platelets in plasma using indium-111-2-mercaptopyridine-N-oxide: preparation and evaluation.

Authors:  M L Thakur; S L McKenney; C H Park
Journal:  J Nucl Med       Date:  1985-05       Impact factor: 10.057

8.  Cell labelling and cell damage with indium-111 acetylacetone-an alternative to indium 111 oxine.

Authors:  H J Danpure; S Osman
Journal:  Br J Radiol       Date:  1981-07       Impact factor: 3.039

9.  Indium-III: a new radionuclide label for studying human platelet kinetics.

Authors:  W A Heaton; H H Davis; M J Welch; C J Mathias; J H Joist; L A Sherman; B A Siegel
Journal:  Br J Haematol       Date:  1979-08       Impact factor: 6.998

10.  Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.

Authors:  H H Davis; W A Heaton; B A Siegel; C J Mathias; J H Joist; L A Sherman; M J Welch
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.